Moore Capital Management LP Takes Position in UnitedHealth Group Incorporated $UNH

Moore Capital Management LP acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 5,000 shares of the healthcare conglomerate’s stock, valued at approximately $2,078,000.

Other large investors also recently modified their holdings of the company. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter worth $4,376,167,000. Corient Private Wealth LP bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $245,516,000. Legal & General Group Plc bought a new position in UnitedHealth Group during the second quarter valued at about $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $2,019,844,000. Finally, BlackRock Inc. increased its position in shares of UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $389.92 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The firm’s 50-day moving average price is $412.95 and its two-hundred day moving average price is $361.54. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $349.99 billion, a price-to-earnings ratio of 25.09, a P/E/G ratio of 1.36 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same period in the prior year, the company earned $4.08 EPS. UnitedHealth Group’s revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is 59.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent research reports. Oppenheimer lifted their price target on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a research report on Wednesday, May 27th. Robert W. Baird raised shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and increased their price target for the stock from $287.00 to $453.00 in a research report on Thursday, July 16th. Erste Group Bank lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 27th. Finally, Morgan Stanley boosted their price target on UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $456.56.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.